[Form 4] Tivic Health Systems, Inc. Insider Trading Activity
Lisa G. Wolf, Chief Financial Officer of Tivic Health Systems, Inc. (TIVC), was granted 80,000 employee stock options on 08/06/2025. The options have an exercise price of $3.32 and expire on 08/05/2035. The filing shows the options were acquired (reported as an award) and are held directly by the reporting person, with 80,000 derivative securities beneficially owned following the transaction. The grant vests 50% on the first anniversary of the grant and the remaining 50% in twelve equal quarterly installments, such that the award is fully vested on the fourth anniversary.
Lisa G. Wolf, Chief Financial Officer di Tivic Health Systems, Inc. (TIVC), ha ricevuto 80,000 opzioni azionarie per dipendenti in data 08/06/2025. Le opzioni hanno un prezzo di esercizio di $3.32 e scadono il 08/05/2035. La comunicazione indica che le opzioni sono state acquisite (riportate come assegnazione) e sono detenute direttamente dalla persona segnalante, con 80,000 strumenti derivati di cui 猫 beneficiaria a seguito della transazione. L'assegnazione matura per il 50% al primo anniversario della concessione e il restante 50% in dodici rate trimestrali uguali, in modo che l'assegnazione sia interamente maturata al quarto anniversario.
Lisa G. Wolf, directora financiera de Tivic Health Systems, Inc. (TIVC), recibi贸 80,000 opciones sobre acciones para empleados el 08/06/2025. Las opciones tienen un precio de ejercicio de $3.32 y vencen el 08/05/2035. La presentaci贸n indica que las opciones fueron adquiridas (reportadas como una adjudicaci贸n) y se mantienen directamente por la persona informante, con 80,000 valores derivados de los que es beneficiaria tras la transacci贸n. La concesi贸n confiere derechos al 50% en el primer aniversario de la adjudicaci贸n y al 50% restante en doce cuotas trimestrales iguales, de modo que la adjudicaci贸n queda totalmente consolidada en el cuarto aniversario.
Tivic Health Systems, Inc. (TIVC)鞚� 鞛毂呾瀯鞛�(Chief Financial Officer)鞚� Lisa G. Wolf電� 08/06/2025鞐� 80,000欤检潣 膦呾梾鞗� 鞀ろ啞鞓奠厴鞚� 攵�鞐皼鞎橃姷雼堧嫟. 頃措嫻 鞓奠厴鞚� 頄夓偓臧�瓴╈潃 $3.32鞚措┌ 毵岆鞚检潃 08/05/2035鞛呺媹雼�. 鞝滌稖靹滊鞐愲姅 鞓奠厴鞚� 旆摑霅� 瓴冹溂搿�(靾橃棳搿� 氤搓碃霅�) 旮办灛霅橃柎 鞛堨溂氅� 鞁犼碃鞚胳棎 鞚橅暣 歆侅为 氤挫湢霅橁碃, 瓯半灅 鞚错泟 80,000臧滌潣 韺岇儩歃濌秾鞚� 鞁れ鞝侅溂搿� 靻岇湢頃橁碃 鞛堧姅 瓴冹溂搿� 雮橅儉雮� 鞛堨姷雼堧嫟. 靾橃棳攵勳潃 靾橃棳鞚检潣 觳� 旮半厫鞚检棎 50%臧� 甓岆Μ旆摑霅橁碃 雮橂ǜ歆� 50%電� 霃欕摫頃� 12須岇潣 攵勱赴氤� 頃犽秬搿� 甓岆Μ旆摑頃橃棳 雱� 氩堨Ц 旮半厫鞚检棎 鞝勲秬 甓岆Μ旆摑霅╇媹雼�.
Lisa G. Wolf, directrice financi猫re de Tivic Health Systems, Inc. (TIVC), s'est vu accorder 80 000 options d'achat d'actions pour employ茅s le 08/06/2025. Les options ont un prix d'exercice de $3.32 et expirent le 08/05/2035. Le d茅p么t indique que les options ont 茅t茅 acquises (d茅clar茅es comme une attribution) et sont d茅tenues directement par la personne d茅clarante, avec 80 000 titres d茅riv茅s dont elle est b茅n茅ficiaire 脿 la suite de la transaction. La subvention est acquise 脿 hauteur de 50 % au premier anniversaire de l'attribution et les 50 % restants en douze versements trimestriels 茅gaux, de sorte que l'attribution est totalement acquise au quatri猫me anniversaire.
Lisa G. Wolf, Chief Financial Officer von Tivic Health Systems, Inc. (TIVC), wurde am 08/06/2025 mit 80.000 Mitarbeiter-Aktienoptionen ausgestattet. Die Optionen haben einen Aus眉bungspreis von $3.32 und laufen am 08/05/2035 ab. Die Einreichung weist aus, dass die Optionen erworben wurden (als Zuteilung gemeldet) und von der meldenden Person direkt gehalten werden, wobei nach der Transaktion 80.000 derivative Wertpapiere wirtschaftlich gehalten werden. Die Zuteilung wird zu 50 % am ersten Jahrestag der Gew盲hrung unverfallbar und die restlichen 50 % in zw枚lf gleichen viertelj盲hrlichen Raten, so dass die Zuwendung am vierten Jahrestag vollst盲ndig unverfallbar ist.
- 80,000 employee stock options granted to Lisa G. Wolf (CFO) recorded on 08/06/2025.
- Exercise price $3.32 with a defined vesting schedule and expiration 08/05/2035, providing clear terms.
- None.
Insights
TL;DR: Routine executive option grant increasing CFO's direct holdings by 80,000 options at a $3.32 strike.
The Form 4 documents a standard equity compensation event: an 80,000 employee stock option award to the CFO recorded on 08/06/2025 with a $3.32 exercise price and an 08/05/2035 expiration. The post-transaction beneficial ownership reported is 80,000 derivative securities held directly. This is a compensation-related issuance rather than a market sale or purchase, and the vesting schedule (50% at one year, remainder over 12 quarterly installments) clarifies when economic interest vests.
TL;DR: Award follows a typical multi-year vesting schedule and was timely disclosed on Form 4.
The record includes a clear vesting timeline and ten-year contractual life (expiration 08/05/2035), consistent with common executive option grants. Reporting identifies Lisa G. Wolf as the reporting person and Chief Financial Officer and indicates direct ownership of the derivative securities after the grant. The Form 4 shows compliance with Section 16 reporting for insider awards.
Lisa G. Wolf, Chief Financial Officer di Tivic Health Systems, Inc. (TIVC), ha ricevuto 80,000 opzioni azionarie per dipendenti in data 08/06/2025. Le opzioni hanno un prezzo di esercizio di $3.32 e scadono il 08/05/2035. La comunicazione indica che le opzioni sono state acquisite (riportate come assegnazione) e sono detenute direttamente dalla persona segnalante, con 80,000 strumenti derivati di cui 猫 beneficiaria a seguito della transazione. L'assegnazione matura per il 50% al primo anniversario della concessione e il restante 50% in dodici rate trimestrali uguali, in modo che l'assegnazione sia interamente maturata al quarto anniversario.
Lisa G. Wolf, directora financiera de Tivic Health Systems, Inc. (TIVC), recibi贸 80,000 opciones sobre acciones para empleados el 08/06/2025. Las opciones tienen un precio de ejercicio de $3.32 y vencen el 08/05/2035. La presentaci贸n indica que las opciones fueron adquiridas (reportadas como una adjudicaci贸n) y se mantienen directamente por la persona informante, con 80,000 valores derivados de los que es beneficiaria tras la transacci贸n. La concesi贸n confiere derechos al 50% en el primer aniversario de la adjudicaci贸n y al 50% restante en doce cuotas trimestrales iguales, de modo que la adjudicaci贸n queda totalmente consolidada en el cuarto aniversario.
Tivic Health Systems, Inc. (TIVC)鞚� 鞛毂呾瀯鞛�(Chief Financial Officer)鞚� Lisa G. Wolf電� 08/06/2025鞐� 80,000欤检潣 膦呾梾鞗� 鞀ろ啞鞓奠厴鞚� 攵�鞐皼鞎橃姷雼堧嫟. 頃措嫻 鞓奠厴鞚� 頄夓偓臧�瓴╈潃 $3.32鞚措┌ 毵岆鞚检潃 08/05/2035鞛呺媹雼�. 鞝滌稖靹滊鞐愲姅 鞓奠厴鞚� 旆摑霅� 瓴冹溂搿�(靾橃棳搿� 氤搓碃霅�) 旮办灛霅橃柎 鞛堨溂氅� 鞁犼碃鞚胳棎 鞚橅暣 歆侅为 氤挫湢霅橁碃, 瓯半灅 鞚错泟 80,000臧滌潣 韺岇儩歃濌秾鞚� 鞁れ鞝侅溂搿� 靻岇湢頃橁碃 鞛堧姅 瓴冹溂搿� 雮橅儉雮� 鞛堨姷雼堧嫟. 靾橃棳攵勳潃 靾橃棳鞚检潣 觳� 旮半厫鞚检棎 50%臧� 甓岆Μ旆摑霅橁碃 雮橂ǜ歆� 50%電� 霃欕摫頃� 12須岇潣 攵勱赴氤� 頃犽秬搿� 甓岆Μ旆摑頃橃棳 雱� 氩堨Ц 旮半厫鞚检棎 鞝勲秬 甓岆Μ旆摑霅╇媹雼�.
Lisa G. Wolf, directrice financi猫re de Tivic Health Systems, Inc. (TIVC), s'est vu accorder 80 000 options d'achat d'actions pour employ茅s le 08/06/2025. Les options ont un prix d'exercice de $3.32 et expirent le 08/05/2035. Le d茅p么t indique que les options ont 茅t茅 acquises (d茅clar茅es comme une attribution) et sont d茅tenues directement par la personne d茅clarante, avec 80 000 titres d茅riv茅s dont elle est b茅n茅ficiaire 脿 la suite de la transaction. La subvention est acquise 脿 hauteur de 50 % au premier anniversaire de l'attribution et les 50 % restants en douze versements trimestriels 茅gaux, de sorte que l'attribution est totalement acquise au quatri猫me anniversaire.
Lisa G. Wolf, Chief Financial Officer von Tivic Health Systems, Inc. (TIVC), wurde am 08/06/2025 mit 80.000 Mitarbeiter-Aktienoptionen ausgestattet. Die Optionen haben einen Aus眉bungspreis von $3.32 und laufen am 08/05/2035 ab. Die Einreichung weist aus, dass die Optionen erworben wurden (als Zuteilung gemeldet) und von der meldenden Person direkt gehalten werden, wobei nach der Transaktion 80.000 derivative Wertpapiere wirtschaftlich gehalten werden. Die Zuteilung wird zu 50 % am ersten Jahrestag der Gew盲hrung unverfallbar und die restlichen 50 % in zw枚lf gleichen viertelj盲hrlichen Raten, so dass die Zuwendung am vierten Jahrestag vollst盲ndig unverfallbar ist.
FAQ
What did Tivic Health (TIVC) disclose in the Form 4 filed by its CFO?
How many options were granted and what is the exercise price (TIVC)?
What is the vesting schedule for the options reported on Form 4 (TIVC)?
When do the options expire according to the Form 4 for TIVC?
Does the Form 4 show direct or indirect ownership after the transaction (TIVC)?
